Article
TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.
Pharmacogenomics - 1 Apr 2009
Alfirevic Ana, Vilar F Javier, Alsbou Mohammed, Jawaid Ansar, Thomson Wendy, Ollier William E R, Bowman Clive E, Delrieu Olivier, Park B Kevin, Pirmohamed Munir
Abstract excerpt
AIMS: Sulfamethoxazole in combination with trimethoprim (cotrimoxazole) is used for prophylaxis and treatment of several opportunistic infections in HIV-infected patients. It is associated with a high incidence of hypersensitivity reactions, which is thought to have an immune basis. Genetic polymorphisms in MHC are known to predispose to hypersensitivity reactions to a structurally diverse group of drugs in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
